Understanding Ethnic Small Business: A Case Study of Marrickville

Ethnic small businesses are an increasingly important feature of economic life in Australian cities. Which groups are most likely to go into this sector, and what are the factors which make for ‘success’? What is the price for survival in terms of working conditions and family life, and what are the fruits of success? These are some of the questions being investigated in a two-year study of ethnic small business in the Sydney region. This paper provides the first report from the study, examining the development of Greek and Vietnamese businesses in the inner suburb of Marrickville.     

Do Interactions between Unemployment Insurance and Sickness Insurance Affect Transitions to Employment?

Previous research suggests that there are substantial interactions between the unemployment and sickness insurance in Sweden. Moral hazard arises in the interplay between these insurance systems, as by reporting sick an unemployed person can postpone unemployment insurance expiration and sometimes receive considerably higher benefits. I examine whether these interactions affect the transition rate to employment. To do this I use a reform that greatly reduced the incentives to transfer to sickness benefits. Although there is evidence that this reform effectively lowered the incidence of sick reports among the unemployed, I do not find that the reduced sick report rate in turn affected the transition rate to employment.     

The regulatory environment for migrant and women entrepreneurs

This study explores the impact of the underlying assumptions in the regulatory environments of two national contexts, Turkey and the Netherlands, on the entrepreneurship of Turkish women. It uses discourses on gender, ethnicity and entrepreneurship. The results indicate that these regulatory environments are immersed with male gendering ideology and give a secondary position to women and migrant entrepreneurs. Accordingly, women and migrant entrepreneurs are confined by the support provided to them by both governmental and non-governmental organizations. Turkish women entrepreneurs are restricted in networking; access to institutions; and funding by the programmes, initiatives or regulations that their enterprises receive support from. This study contributes to existing literature on migrant and women entrepreneurship by discursively analysing underlying assumptions regarding these groups in two different national contexts.     

Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development

The addendum of the ICH E9 guideline on the statistical principles for clinical trials introduced the estimand framework. The framework is designed to strengthen the dialog between different stakeholders, to introduce greater clarity in the clinical trial objectives and to provide alignment between the estimand and statistical analysis. Estimand framework related publications thus far have mainly focused on randomized clinical trials. The intention of the Early Development Estimand Nexus (EDEN), a task force of the cross-industry Oncology Estimand Working Group ( www.oncoestimand.org ), is to apply it to single arms Phase 1b or Phase 2 trials designed to detect a treatment-related efficacy signal, typically measured by objective response rate. Key recommendations regarding the estimand attributes include that in a single arm early clinical trial, the treatment attribute should start when the first dose is received by the participant. Focusing on the estimation of an absolute effect, the population-level summary measure should reflect only the property used for the estimation. Another major component introduced in the ICH E9 addendum is the definition of intercurrent events and the associated possible ways to handle them. Different strategies reflect different clinical questions of interest that can be answered based on the journeys an individual subject can take during a trial. We provide detailed strategy recommendations for intercurrent events typically seen in early-stage oncology. We highlight where implicit assumptions should be made transparent as whenever follow-up is suspended, a while-on-treatment strategy is implied.